Publications and Presentations


Casalena G, Daehn I, Bottinger E. Transforming growth factor-β, bioenergetics, and mitochondria in renal disease. Seminars in Nephrology, Vol 32, No 3, May 2012, pp 295-303.

Gottesman O, Drill E, Lotay V, Bottinger E, Peter I. Can genetic pleiotropy replicate common clinical constellations of cardiovascular disease and risk? PLoS One, Vol 7, Issue 9, September 2012.

Li H, Gan W, Lu L, Dong X, Han X, Hu C, Yang Z, Sun L, Bao W, Li P, He M, Sun L, Wang Y, Zhu J, Ning Q, Tang Y, Zhang R, Wen J, Wang D, Zhu X, Guo K, Zuo X, Guo X, Yang H, Zhou X; DIAGRAM Consortium; AGEN-T2D Consortium, Zhang X, Qi L, Loos RJ, Hu FB, Wu T, Liu Y, Liu L, Yang Z, Hu R, Jia W, Ji L, Li Y, Lin X. A Genome-Wide Association Study Identifies GRK5 and RASGRP1 as Type 2 Diabetes Loci in Chinese Hans. Diabetes, 2012 Sept 6.

Lipkowitz MS, Freedman BI, Langefeld CD, Comeau ME, Bowden DW, Kao WH, Astor BC, Bottinger EP, Iyengar SK, Klotman PE, Freedman RG, Zhang W, Parekh RS, Choi MJ, Nelson GW, Winkler CA, Kopp JB; the AASK Investigators. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney International, 2012 Jul 25. doi: 10.1038/ki.2012.263.

Loos RJ, Schadt EE. This I believe: gaining new insights through integrating "old" data. Frontiers in Genetics, 2012;3:137. Epub 2012 Jul 31.

Morris AP, Voight BF, Teslovich TM, Ferreira T, Segrè AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nature Genetics, 2012 Sep;44(9):981-90. doi: 10.1038/ng.2383.

Streicher SA, Sanderson SC, Jabs EW, Diefenbach M, Smirnoff M, Peter I, Horowitz CR, Brenner B, Richardson LD. Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: a focus group study. Journal of Community Genetics, 2011 Sep;2(3):153-63. Epub 2011 Jun 7.

Tayo BO, Kramer H, Salako BL, Gottesman O, McKenzie CA, Ogunniyi A, Bottinger EP, Cooper RS. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians. International Urology and Nephrology, 2012 Sep 7.

Tayo BO, Teil M, Tong L, Qin H, Khitrov G, Zhang W, Song Q, Gottesman O, Zhu X, Pereira AC, Cooper RS, Bottinger EP. Genetic background of patients from a university medical center in Manhattan: implications for personalized medicine. PLoS One, 2011 May 4;6(5):e19166.

Vimaleswaran KS, Tachmazidou I, Zhao JH, Hirschhorn JN, Dudbridge F, Loos RJ. Candidate genes for obesity-susceptibility show enriched association within a large genome-wide association study for BMI. Human Molecular Genetics, 2012, Vol. 21, No. 20, pp 4537–4542.

Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, et al. FTO genotype is associated with phenotypic variability of body mass index. Nature, 2012 Oct 11;490(7419):267-72. doi: 10.1038/nature11401.


Biobank Presentation – Research Day 9/5/2012 [PDF]